Here, we performed in-depth molecular analyses to unravel the key MUC13-mediated signaling pathways involved in intestinal barrier dysfunction upon IL-22 activation in IBD using in vitro, in vivo and translational approaches. Here, MUC13 is linked to inflammatory bowel disease.